Metrics: Teen vaccine market poised for growth
With the global vaccine market set to double by 2010, hitting $19 billion, development companies are increasingly focused on new vaccines for teens. Vaccines for bacterial meningitis, whooping cough and human papillomavirus are being studied among teens, who could account for 15 percent of the total market. Some of the new vaccines are being marketed directly to parents, and costs are often significantly higher than earlier generations of vaccines.
- check out the article on vaccines from The Wall Street Journal (sub. req.)
More stories about Vaccines
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
